Cyclophosphamide 2 GM/10 ML VL 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM1FK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,052
Award facts
- Contract value 100% obligated
- $2,051.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,051.90 to AmerisourceBergen Drug Corp for the supply of Cyclophosphamide 2 GM/10 ML vials (10 milliliter units) with an ultimate completion date of December 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the federal government's pharmaceutical supply chain support. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the order at its corporate office location.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Medical Supply Chain relies on such contracts to ensure consistent availability of critical medications, including specialty pharmaceuticals like Cyclophosphamide, which is commonly used in military and federal healthcare settings for cancer treatment and immunosuppressive therapy.
Quick answers
Who was awarded contract SPE2DR26FM1FK?
SPE2DR26FM1FK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 24, 2025.
How much is contract SPE2DR26FM1FK worth?
The government has obligated $2,052 on SPE2DR26FM1FK.
Is contract SPE2DR26FM1FK an order under another contract?
Yes. SPE2DR26FM1FK is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1FK competed?
The extent of competition for SPE2DR26FM1FK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award